Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Selecta Biosciences, Inc. (1S7.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
1.5705+0.0075 (+0.48%)
At close: 03:59PM CET
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in EUR

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 1/28/2023
Current
Market Cap (intraday)
N/A
Enterprise Value
N/A
Trailing P/E
N/A
Forward P/E
N/A
PEG Ratio (5 yr expected)
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
N/A
Enterprise Value/Revenue
N/A
Enterprise Value/EBITDA
N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 0.96
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 32.5010
52 Week Low 30.6260
50-Day Moving Average 31.2290
200-Day Moving Average 31.3738

Share Statistics

Avg Vol (3 month) 360
Avg Vol (10 day) 372
Shares Outstanding 5116.65M
Implied Shares Outstanding 6N/A
Float 8101.77M
% Held by Insiders 125.17%
% Held by Institutions 146.75%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in USD.

Fiscal Year

Fiscal Year Ends Dec 31, 2021
Most Recent Quarter (mrq)Jun 30, 2022

Profitability

Profit Margin 24.85%
Operating Margin (ttm)20.95%

Management Effectiveness

Return on Assets (ttm)9.07%
Return on Equity (ttm)74.31%

Income Statement

Revenue (ttm)127.64M
Revenue Per Share (ttm)1.01
Quarterly Revenue Growth (yoy)99.70%
Gross Profit (ttm)16.34M
EBITDA 27.48M
Net Income Avi to Common (ttm)31.72M
Diluted EPS (ttm)-0.5650
Quarterly Earnings Growth (yoy)88.40%

Balance Sheet

Total Cash (mrq)142.06M
Total Cash Per Share (mrq)0.93
Total Debt (mrq)35.06M
Total Debt/Equity (mrq)39.13
Current Ratio (mrq)5.11
Book Value Per Share (mrq)-0.17

Cash Flow Statement

Operating Cash Flow (ttm)-66.34M
Levered Free Cash Flow (ttm)-42.67M
Advertisement
Advertisement